---
title: "This common liver supplement could boost cancer treatment success"
date: 2025-10-17T12:37:08.000Z
category: Health
externalLink: "https://www.sciencedaily.com/releases/2025/10/251017081515.htm"
image: ""
excerpt: "Salk Institute scientists discovered that bile acids in the liver can weaken immune cell function, making immunotherapy less effective against liver cancer. They pinpointed specific bile acids that suppress T cells and found that supplementing with UDCA reversed the effect, controlling tumor growth in mice. Since UDCA is already used for liver disease, it could quickly translate into clinical trials.â€¦"
---